Actinobaculum suis (Cystitis and Pyelonephritis)
LEVELS: Highly unlikely: No controls necessary; Highly unlikely: No evidence of non-foodborne zoonotic transmission; Highly effective: Routine on-farm biosecurity measures are effective in preventing farm-to-farm transmission; Moderate: Clinical signs not unique but existing tests available at local/regional laboratory(s); Minor: Low prevalence, typically non-lethal infection with recovery very likely; Negligible: Little or no market disruption when disease occurs on one or more farms; Minimal risk: Agent inherently unlikely to develop clinically important resistance to antibacterial or antiviral treatments; Minimal risk: Antibacterial or antiviral treatments rarely occur, or are typically limited to short-course individual animal therapy; Available but with uncertain efficacy: Limited treatments available in US or are only effective in some situations; No availability: Effective vaccines not currently available in the US (or have not been developed); Highly likely: Can be eradicated using existing tools and knowledge
Criteria Levels
- Foodborne Zoonotic Transmission: No foodborne transmission
- Non-Foodborne Zoonotic Transmission: No non-foodborne zoonotic transmission
- Beyond-Farm Spread Potential: Contained by standard biosecurity
- Detection Difficulty: Moderate detection requiring specialized testing
- Financial Impact - Mortality and Morbidity Costs: Sporadic losses with occasional significant impacts
- Financial Impact - Prevention and Control Costs: Little market disruption
- Antimicrobial Resistance - Pathogen Risk: No AMR concern
- Antimicrobial Resistance - Treatment Impact: Minimal AMR concern from disease management
- Treatment Availability: Effective treatments usually available
- Vaccine Availability: No effective vaccine
- Eradication Feasibility: Achievable eradication through management
Detailed Justification
1. Foodborne Zoonotic Transmission
Level: No foodborne transmission
The chapter explicitly states: "It is not a public health concern." A. suis causes urinary tract disease in sows and is carried by boars; there is no mechanism for foodborne transmission to humans from infected urinary tissue.
2. Non-Foodborne Zoonotic Transmission
Level: No non-foodborne zoonotic transmission
There is no mention of human infection in the chapter. The organism has very specific host and tissue tropism - colonizing the preputial diverticulum of boars and causing ascending urinary tract infection in sows. No occupational or contact-based human infections are described.
3. Beyond-Farm Spread Potential
Level: Contained by standard biosecurity
The epidemiology is tightly linked to venereal transmission: - "Most male pigs, aged 6 months or more, harbor A. suis in the preputial diverticulum" - "Most cases occur in females 1–3 weeks after mating with an infected boar" - "The use of artificial insemination may help prevent disease"
Disease requires introduction of infected boars or natural service with carriers. Standard biosecurity practices (AI, quarantine, testing) effectively prevent introduction. Footwear contamination has been reported (Carr and Walton 1990), but this represents localized contamination rather than aerosol or long-distance spread.
4. Detection Difficulty
Level: Moderate detection requiring specialized testing
Clinical suspicion is possible based on timing and presentation: - "The presence of hematuria 2–3 weeks after service by a boar suggests A. suis cystitis and pyelonephritis" - "Diagnosis is based on clinical signs and bacterial culture of urine or the urinary tract"
However, confirmation requires specialized culture conditions: - "Anaerobic incubation for 4 days is essential for isolation from urine or affected tissue" - "A selective medium for the isolation of A. suis has been described"
PCR has been developed that is "far more sensitive than traditional culture" (detecting 8.9% of sow urine samples vs 0% by culture), suggesting conventional culture frequently misses infection. AFLP typing enables strain differentiation. The requirement for anaerobic culture and specialized media, plus subclinical carriage in boars (82.2% positive by PCR vs 31% by culture), indicates moderate detection difficulty.
5. Financial Impact - Mortality and Morbidity Costs
Level: Sporadic losses with occasional significant impacts
The disease primarily affects individual sows following mating: - "Clinically affected sows frequently die from renal failure" - "Affected sows or gilts may die suddenly or be found ill, depressed, or thirsty" - Disease is limited to "individual or small groups of sows"
Impact is sporadic rather than herd-wide. The loss of individual sows to renal failure represents occasional significant impact, but this is not a high-prevalence endemic condition causing sustained population-level losses.
6. Financial Impact - Prevention and Control Costs
Level: Little market disruption
A. suis is not a regulated disease. There are no trade restrictions, no slaughter surveillance issues, and no market access concerns. Prevention primarily involves adoption of AI, which is already standard practice in commercial operations. The disease has minimal impact on market dynamics.
7. Antimicrobial Resistance - Pathogen Risk
Level: No AMR concern
Historical data showed sensitivity to penicillin and tetracyclines. More recent Brazilian work has observed "elevated MICs to tetracyclines, macrolides, and fluoroquinolones" (Amigo et al. 2019). However, the organism is an obligate swine pathogen with no zoonotic potential, confined to individual animal treatment scenarios, and not a reservoir for resistance genes of broader concern. The AMR observed is clinically relevant for treatment selection but does not represent a public health or One Health concern.
8. Antimicrobial Resistance - Treatment Impact
Level: Minimal AMR concern from disease management
Treatment is sporadic and limited to individual affected sows: - "Antibiotics are frequently effective, but relapses occur" - "Prolonged treatment for 20 days with ampicillin given at 20 mg/kg has been suggested" - "Early slaughter of affected animals is recommended"
The recommended approach favors culling over prolonged treatment for chronically affected animals. This limits antimicrobial use and reduces selection pressure. No population-level antimicrobial programs are employed.
9. Treatment Availability
Level: Effective treatments usually available
Multiple treatment options exist: - "Actinobaculum suis is sensitive in vitro to several antibiotics, including penicillin and tetracyclines" - Beta-lactams remain effective for most isolates - Treatment success depends on early intervention
However, treatment has limitations: - "Relapses occur" - "Chronically affected animals in poor body condition and those that have not responded to treatment should be euthanized"
This indicates that treatment is usually effective for acute cases but may fail in chronic or advanced disease - consistent with "usually available" rather than "highly effective."
10. Vaccine Availability
Level: No effective vaccine
The chapter makes no mention of any vaccine for A. suis - neither commercial nor autogenous products are described. Prevention relies entirely on management practices (AI, avoiding infected boars).
11. Eradication Feasibility
Level: Achievable eradication through management
The organism has a highly specific epidemiology that makes elimination feasible: - Infection requires introduction via infected boars - "The use of artificial insemination may help prevent disease" - Culling of chronically infected animals eliminates reservoir
For farms using exclusively AI with tested semen sources and practicing appropriate culling of affected sows, the organism can be eliminated. This is not eradication at a population level but is readily achievable at the farm or production system level through straightforward management changes.
Summary
Actinobaculum suis represents a sporadic, venereal urinary tract pathogen of sows with no zoonotic significance. Its tight association with natural mating makes it readily controllable through modern AI-based production systems. While affected individuals may die from renal failure, the disease does not cause population-level impacts. Detection requires anaerobic culture or PCR. Treatment is available but has limitations in chronic cases. Prevention through AI is highly effective, making farm-level eradication achievable.